14-day Premium Trial Subscription Sign Up For FreeGet Free

$12.20 (-3.10%)

Volume: 255k

Closed: Dec 08, 2021

Hollow Logo Score: 1.276

ESSA Pharma Inc. Stock Forecast

$12.20 (-3.10%)

Volume: 255k

Closed: Dec 08, 2021

Score Hollow Logo 1.276
Which way will EPIX go? Request
Stop-loss: $11.58 (-5.12%)
Earnings Date: Dec 13, 2021
Key Stats
Beta 1.21
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 44 and the stock is currently not being overbought or oversold

Red day on Wednesday for ESSA Pharma Inc. stock after losing 3.1%
(Updated on Dec 08, 2021)


Buy or Hold candidate since 2021-10-21 Gain 42.19%

The ESSA Pharma Inc. stock price fell by -3.10% on the last day (Wednesday, 8th Dec 2021) from $12.59 to $12.20. During the day the stock fluctuated 5.83% from a day low at $12.09 to a day high of $12.80. The price has risen in 6 of the last 10 days, but is still down by -6.8% for this period. Volume has increased on the last day by 99 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 255 thousand shares were bought and sold for approximately $3.11 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 62.74% during the next 3 months and, with a 90% probability hold a price between $18.21 and $23.65 at the end of this 3-month period.

Signals & Forecast

A sell signal was issued from a pivot top point on Friday, November 26, 2021, and so far it has fallen -11.72%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Some positive signals were issued as well, and these may have some influence on the near short-term development. The ESSA Pharma Inc. stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $12.37. On a fall, the stock will find some support from the long-term average at approximately $11.35. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal.

Support, Risk & Stop-loss

On the downside, the stock finds support just below today's level from accumulated volume at $11.05 and $11.00. There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ESSA Pharma Inc. finds support just below today's level at $11.05. If this is broken, then the next support from accumulated volume will be at $11.00 and $10.15.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.71 between high and low, or 5.83%. For the last week, the stock has had a daily average volatility of 10.19%.

Our recommended stop-loss: $11.58 (-5.12%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 8 days ago.)

Is ESSA Pharma Inc. stock A Buy?

Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.

Current score: 1.276

Predicted Opening Price for ESSA Pharma Inc. of Thursday, December 9, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 9, 2021 Current price
$12.36 $12.20 (Undervalued)
Buy Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Aug 16, 2021 "Oppenheimer" gave "$36.00 - $22.00" rating for EPIX. The price target was changed from $7.81 to 34.5%.

Volatility and Risk
Daily Average Volatility: 10.19 %
Overall Risk: Very High High Medium Low Very Low
Volatility
10.19 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $13.09
Price: $12.20
Support: $11.05

EPIX Insider Trading Show all Trades

INSIDER POWER

26.397

Last 24 transactions
Buy: 1 114 155 | Sell: 42 207 (Shares)
Date Action Amount Person Type
Aug 18, 2021 Buy 250 000 Biotech Growth N V Common Shares
Feb 22, 2021 Buy 57 000 Berger Franklin M Common Shares
Dec 11, 2020 Buy 100 000 Wood David S. Stock Option (Right to Buy)
Dec 11, 2020 Buy 57 500 Cesano Alessandra Stock Option (Right to Buy)
Dec 11, 2020 Buy 16 500 Brettman Ari David Stock Option (Right to Buy)
Show all Insider Trades
INSIDER POWER

26.397

Last 24 transactions
Buy: 1 114 155 | Sell: 42 207 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 13.07 7.10 %
12.80 4.90 %
12.63 3.53 %
Current price: 12.20
Support 12.09 -0.88 %
11.93 -2.25 %
11.66 -4.45 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 13.36 9.51 %
13.11 7.46 %
13.09 7.30 %
Current price 12.20
Support 11.05 -9.43%
11.00 -9.84%
10.15 -16.80%

Click to get the best stock tips daily for free!

About ESSA Pharma Inc.

ESSA Pharma ESSA Pharma Inc., a clinical-stage pharmaceutical company, focuses on the development of novel and proprietary therapies for the treatment of prostate cancer. Its product candidate is EPI-506, an oral small molecule pro-drug that blocks the N-terminal domain of the androgen receptor. The company was founded in 2009 and is headquartered in Vancouver, Canada.... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT